FDA Adverse Event Malfunction Summary report: N

VERIFLEX (LIBERTE) CORONARY STENT DELIVERY SYSTEM

MDR report key: 1761110 · Received July 19, 2010

Report

Report Number
2134265-2010-02518
Event Type
Malfunction
Date Received
July 19, 2010
Date of Event
February 7, 2006
Report Date
February 7, 2006
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
MAF
PMA / PMN Number
P040016
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
HU
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS THE DEVICE WAS NOT RETURNED, A TECHNICAL ANALYSIS COULD NOT BE PERFORMED. THE BATCH NUMBER IS UNKNOWN AND THE MANUFACTURING RECORDS FOR THE COMPLAINT DEVICE COULD NOT BE REVIEWED. THE MOST PROBABLE ROOT CAUSE IS OPERATIONAL CONTEXT AS DEVICE PERFORMANCE WAS LIMITED DUE TO ANATOMICAL/PROCEDURAL FACTORS.(B)(4)

Description of Event or Problem · 1

(B)(4). IT WAS REPORTED THAT DURING A CORONARY ARTERY STENTING PROCEDURE INCOMPLETE EXPANSION OF THE STENT OCCURRED. THE PROCEDURE TREATED THREE LESIONS WITHIN TWO VESSELS. TARGET LESION ONE WAS A 2.2X26MM, 84% STENOSED LESION OF THE CIRCUMFLEX ARTERY. A 2.75X32MM LIBERTE STENT WAS PLACED RESULTING IN 0% RESIDUAL STENOSIS. TARGET LESION TWO WAS A 2.2X14MM, 67% STENOSED LESION OF THE CIRCUMFLEX. A 2.75X16MM LIBERTE STENT WAS PLACED RESULTING IN 0% RESIDUAL STENOSIS. TARGET LESION THREE WAS A 3.2X12MM, 66% STENOSIS OF THE LAD (LEFT ANTERIOR DESCENDING). A 3.5X16MM LIBERTE STENT WAS PLACED RESULTING IN 0% RESIDUAL STENOSIS. IT WAS NOTED THAT THE 3.5X16MM LIBERTE STENT WAS UNDER EXPANDED; HOWEVER, NO ADDITIONAL PROCEDURE WAS REQUIRED. THE PATIENT WAS DISCHARGED THE NEXT DAY ON ASA AND CLOPIDOGREL WITH NO FURTHER EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VERIFLEX (LIBERTE) CORONARY STENT DELIVERY SYSTEM STENT, CORONARY MAF BOSTON SCIENTIFIC - GALWAY UNK208

Patients

Seq Age Sex Outcome Treatment
1 78 YR SPRINTER BALLOON